After the required first in-person exam, adults could have follow-ups remotely or in person while they continue taking the stimulant.
Adults prescribed a Schedule II stimulant for ADHD would still need an initial in-person exam, but follow-ups could be remote or in person every six months.
Providers would need to follow up with these patients in person or remotely every six months. This applies to adults prescribed a Schedule II stimulant through telehealth or telemedicine to treat attention-deficit/hyperactivity disorder (ADHD). The patient must first have an in-person examination, as provided by regulation. A follow-up is required every six months for as long as the patient is prescribed the drug.
No hearings or votes scheduled.